PRQR
PRQR
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
5
$1.34M
Insider Sales
0
$0
Total Volume
$1.34M
10 transactions
Net Activity
+$1.34M
Net buying
Sentiment Rating
Strong AccumulationCEO Conviction Index
High Conviction Accumulation
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •Minor cluster buying: 2 unique insiders purchased shares.
- •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
- •High accumulation: total purchase value exceeds $1M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
P - Purchase Insiders
$235.00B total
De Boer Daniel Anton
CEO
$853K total
Filius Bart
Dir
$489K total
Quick Actions
PRQR has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at PRQR (PRQR) engaged in a total of 10 transactions reported via SEC Form 4 filings. Among these, 5 were open-market purchases and 0 were sales. The total volume of insider trading reached $1.34M.
The net insider activity for PRQR shows a net buying bias of $1.34M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 500.0K shares valued at $100.00B on Jul 31, 2026.
Proqr Therapeutics N.v Stock Price Forecast. Should You Buy PRQR?
PRQR Nov 2026 1.000 put (PRQR261120P00001000) stock price, news, quote and history
ProQR Therapeutics (Nasdaq:PRQR) - Stock Analysis
PRQR - ProQR Therapeutics N.V Stock Price and Quote
ProQR Announces Third Quarter 2026 Operating and Financial Results
PRQR Forecast — Price Target — Prediction for 2027
FAQs About PRQR Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for PRQR.